Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Clinical Consequences of Flutemetamol-PET-scanning

NCT02353949 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT02353949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02353949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Clinical Consequences of Flutemetamol-PET-scanning
Lead sponsor
University of Zurich
Phase
Phase 3
Overall status
Terminated
Start date
May 31, 2015
Completion date
December 10, 2019
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, dementia, mild cognitive impairment